Informations générales (source: ClinicalTrials.gov)
Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Observational
Centre Hospitalier Sud Francilien (Voir sur ClinicalTrials)
mars 2024
décembre 2025
12 septembre 2025
Insulin-treated diabetes in dependent or institutionalized patients is often poorly
balanced and continuous glucose measurement is underused. The purpose of this tudy is to
know how smart connected insulin pens and continuous glucose measurement can improve
insulin therapy practice in dependent and/or institutionalized patients?
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CENTRE HOSPITALIER SUD FRANCILIEN | Marie BOULY | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Older than 18 years patient with type 1 or 2 diabetes
- Treated with multiple insulin injections
- Equipped with a continuous glucose measurement system and smart connected insulin
pens at least one month before
- Dependent on a health professional for treatment management.
- Subject informed of the study and not objecting to data collection.
- Older than 18 years patient with type 1 or 2 diabetes
- Treated with multiple insulin injections
- Equipped with a continuous glucose measurement system and smart connected insulin
pens at least one month before
- Dependent on a health professional for treatment management.
- Subject informed of the study and not objecting to data collection.
- Patient refusing study.